Remote Patient Monitoring
Enabling care teams to intervene earlier when needed.
Evinova’s RPM uniquely delivers exclusive toxicity monitoring through science-led, user-centric digital solutions that help mitigate the morbidity of high-grade toxicities and improve patient engagement, retention, and outcomes.
Proven Outcomes
Digestive RPM: Reducing the burden of GI adverse events and critical AE duration


Selected GI AEs include Constipation, Nausea, Decreased appetite, Diarrhea, Vomiting, Enteritis, Colitis, Gastritis (all grade)
Solution
Toxicity goes unreported between visits. Evinova RPM closes that gap.

Built for patients and with patients
Continuous, structured monitoring through the patient-managed app:
Same symptom list, now actively tracked between visits
At-home detection of out-of-range biovital values
Patient prompted - no reliance on memory or initiative
Distinguish daily noise from clinically meaningful deterioration
One app for patients combining PROs, connected devices, and personalised coping tips
Schedule Demo
Earlier insights elevate patient care
The moment deterioration shows, sites see it and act before the next scheduled visit.
Opportunity for sites to intervene proactively
Data-driven insights to guide treatment management
Earlier identification of worsening toxicities
Improved outcomes


Case Study
Proven Benefits - ADCs
Remote patient monitoring for toxicities - pneumonitis and other ILD
Challenges and requirements
Concerns raised across the industry around ADC tolerance profiles with regards to pneumonitis and other ILD.
Recent reviews and presentations at ESMO (2023) highlight the importance of careful patient monitoring, due to preventable pneumonias which are not captured early enough.
Evinova Unified Trial Solution
Module created based on scientific research and added to connected platform.
Branching logic for Key Symptom Monitoring at home
Pulse Ox measurement at home at rest and exertion
Alert to patients to contact site
Alerts to sites to watch out for patient
Includes PROs for oncology
Evidence
RWE of more than 480 patients highlighting that pneumonitis & other ILD are highly symptomatic: 73% symptomatic.
With symptom tracking and pulse ox, the solution is able to detect symptoms 83 days ahead of physicians.
Solution build & AI algorithm insights from a pulmonologist Delphi panel.
Capabilities
Reducing treatment burden with smart digital tools
A growing portfolio of digital solutions focused on the most common symptomatic toxicities affecting patient morbidity
For Patients:
Digitally Reported Symptoms
Remote Monitoring
Remote Blood Sampling
Remote Imaging
For Sites:
Smart Notifications
Advanced Analytics
Documentation & Reports
Data Visualization
Coverage
Evinova's RPM Modules
Mouth & Throat
Stomatitis, Oral Thrush
Pulmonary
ILD and Pneumonitis
Digestive
Nausea, Vomiting, Diarrhea
Ocular
Keratitis
Fever
Cytokine Release Syndrome
Pain
Why Evinova?
Evinova is redefining clinical trial software with scalable, AI-native Platform for digital and decentralized trials. Let’s build smarter, faster, and more inclusive trials together.
Schedule Demo